Welcome to the Essential Eye Cancer Podcast with Dr. Paul Finger. Dr. Finger is an internationally recognized eye cancer specialist offering excellence in ophthalmic oncology care. He is Director of The New York Eye Cancer Center and author of the web site eyecancer.com. He has authored over 300 scientific articles, invented new methods for eye cancer diagnosis and treatment and always strives for excellence in his patient's care. The following PodCast is presented to teach you about a unique aspect of eye cancer care. This information reflects Dr. Fingers' research, teaching, and experience caring for patients over the last 35 years.
Essential Eye Cancer Podcast
Claim This Podcastby Dr. Paul Finger, MD
5.0(5 reviews)
37 episodes
Updated Daily
Accepts GuestsHas SponsorsLocation 🇺🇸
Podcast Overview
Welcome to the Essential Eye Cancer Podcast with Dr. Paul Finger. Dr. Finger is an internationally recognized eye cancer specialist offering excellence in ophthalmic oncology care. He is Director of The New York Eye Cancer Center and author of the web site eyecancer.com. He has authored over 300 scientific articles, invented new methods for eye cancer diagnosis and treatment and always strives for excellence in his patient's care. The following PodCast is presented to teach you about a unique aspect of eye cancer care. This information reflects Dr. Fingers' research, teaching, and experience caring for patients over the last 35 years.
Language
🇺🇲
Publishing Since
2/5/2020
1 verified contact email on file for Essential Eye Cancer Podcast
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
June 24, 2026
Dr. Finger's 2025 Zimmerman Lecture at the American Academy of Ophthalmology
<p>Presented at AAO 2025, © American Academy of Ophthalmology. Watch Dr. Finger join this exciting symposium, tailored for ophthalmologists across all subspecialties. Emphasizing the power of collaboration, Dr. Finger will share how the American Joint Committee on Cancer Ophthalmic Oncology Task Force and the union for International Cancer Control worked together to create, validate, and establish the first universally accepted eye cancer staging system language, which enabled multi-center international data sharing and critical evidence-based discoveries.</p> <p>"Inspired by Dr. Zimmerman's visionary work, I'll share how relentless curiosity, global collaboration, and patient-centered innovation have transformed eye cancer care - turning once-blinding diagnoses into pathway of hope, sight, and survival." -Dr. Paul T. Finger</p>
October 26, 2020
Conjunctival Tumors Overview - EEC035
<p>Tumors and cancers commonly occur on the conjunctiva and often grow onto the corneal surface. Both conjunctival melanoma and squamous carcinoma have been associated with sun (ultraviolet UV-ray) exposure, so Dr. Finger says, "Think of Sunglasses as Sunblock for your Eyes.®" Commonly treated with observation for growth, surgical removal or a combination of surgery and freezing "cryotherapy," over the last 10 years more and more patients are treated with immunotherapy or chemotherapy eye drops. Of course, your doctor may need to biopsy first, but at The New York Eye Cancer Center, most patients don't need extensive surgery. </p> <p>Paul T. Finger, MD, FACS<br /> The New York Eye Cancer Center<br /> 115 East 61st Street<br /> New York City, New York, USA<br /> 10065</p> <p>E-mail: <a href= "mailto:pfinger@eyecancer.com">pfinger@eyecancer.com</a></p> <p>Telephone: (011) 212 832 8170</p>
October 5, 2020
Large Clinical Trials Won't Change Physics - EEC034
<p>This Podcast takes a closer look at what I do to maximize eye radiation outcomes and minimize patient risk. Until we have a treatment for metastatic ocular melanoma, destruction of the intraocular tumor will be the best way to prevent and thus "treat" metastasis. Across the world, each eye cancer center has its own radiation methods to destroy choroidal melanomas. However, a closer look at the methods of plaque selection and implementation reveals significant differences. This Podcast discusses basic plaque design, construction, and dose calculations. I explain why certain methods/plaques are more likely to result in eye cancer control. This Podcast is targeted to help eye cancer specialists improve their results.</p> <p>Paul T. Finger, MD, FACS<br /> The New York Eye Cancer Center<br /> 115 East 61st Street<br /> New York City, New York, USA<br /> 10065</p> <p>E-mail: <a href= "mailto:pfinger@eyecancer.com">pfinger@eyecancer.com</a></p> <p>Telephone: (011) 212 832 8170</p>
37 total episodes available
Deep-dive analytics for Essential Eye Cancer Podcast
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Essential Eye Cancer Podcast?
- How often does this podcast release new episodes?
This podcast updates daily.
- Where can I listen to this podcast?
This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
No, this podcast does not typically feature guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.